slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8711 USD | -2,40% | -14,60% | -96,79% |
Vakgebied
Aantal werknemers: 44
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 4 | 100,0 % | 24 | 100,0 % | +454,42% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 24 | 100,0 % | +454,42% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steve Slilaty
CEO | Chief Executive Officer | 71 | 15-10-09 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 15-10-09 |
Marc Beaudoin
COO | Chief Operating Officer | - | 25/01 |
Chief Tech/Sci/R&D Officer | 60 | 01-02-16 | |
Malek Chamoun
PRN | Corporate Officer/Principal | 39 | 25/01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Natan
BRD | Director/Board Member | 70 | 01-02-22 |
Steve Slilaty
CEO | Chief Executive Officer | 71 | 15-10-09 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 15-10-09 |
Chief Tech/Sci/R&D Officer | 60 | 01-02-16 | |
Rabi Kiderchah
BRD | Director/Board Member | 51 | 31-10-21 |
Andrew Keller
BRD | Director/Board Member | 70 | 10-02-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 994 529 | 900 534 ( 90,55 %) | 0 | 90,55 % |
Aandeel B | 0 | 10 000 | 0 | 0 |
Bedrijfsgegevens
Sunshine Biopharma, Inc.
1177 Avenue of the Americas 5th Floor
10036, New York
+
http://www.sunshinebiopharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-96,79% | 866K | |
+31,06% | 682 mld. | |
+30,35% | 586 mld. | |
-3,42% | 364 mld. | |
+18,02% | 327 mld. | |
+4,27% | 285 mld. | |
+15,53% | 240 mld. | |
+10,16% | 209 mld. | |
-8,14% | 203 mld. | |
+8,12% | 165 mld. |
- Beurs
- Aandelen
- Koers SBFM
- Onderneming Sunshine Biopharma, Inc.